Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

104.01

+0.03 (0.03%)

At close: May 29, 2026, 4:00 PM EDT

104.00

-0.01 (-0.01%)

After-hours: May 29, 2026, 7:54 PM EDT

Inhibrx Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	161.66	124.22	152.6	277.92	273.87	131.3
Cash & Short-Term Investments	161.66	124.22	152.6	277.92	273.87	131.3
Cash Growth	-25.34%	-18.60%	-45.09%	1.48%	108.58%	2.05%
Accounts Receivable	-	-	0.2	0.78	0.24	0.37
Other Receivables	0.19	0.18	0.22	-	0.01	0.51
Total Trade Receivables	0.19	0.18	0.42	0.78	0.26	0.88
Other Current Assets	9.5	8.44	7.38	16.66	6.37	6.93
Total Current Assets	171.34	132.83	160.4	295.36	280.49	139.11
Net Property, Plant & Equipment	8.25	9.27	13.54	9.37	7.22	9.49
Other Long-Term Assets	4.38	4.38	6.83	3.16	3.16	1.85
Total Assets	183.97	146.48	180.77	307.89	290.88	150.45
Accounts Payable	8.76	5.94	9.25	10.95	8.33	-
Accrued Expenses	15.34	25.53	29.89	43.3	17.22	9.62
Current Portion of Leases	2.41	2.33	1.6	2.06	1.86	1.67
Unearned Revenue	-	-	-	-	0.17	2.03
Total Current Liabilities	26.51	33.8	40.73	56.31	27.58	22.45
Long-Term Debt	174.99	100.56	-	206.97	202.07	70.47
Long-Term Leases	3.5	4.13	6.45	1.11	3.17	5.03
Other Long-Term Liabilities	-	-	-	-	-	0.11
Total Long-Term Liabilities	178.49	104.69	6.45	208.08	205.24	75.61
Total Liabilities	205	138.49	47.18	264.39	232.82	98.07
Common Stock	0	0	0	0.01	0	0
Additional Paid-in Capital	258.59	254.18	239.72	657.23	430.43	279.53
Retained Earnings	-279.63	-246.19	-106.13	-613.73	-372.37	-227.15
Shareholders' Equity	-21.04	7.99	133.58	43.5	58.06	52.38
Total Liabilities & Equity	183.97	146.48	180.77	307.89	290.88	150.45
Total Debt	180.9	107.01	8.05	210.14	207.1	77.18
Net Cash (Debt)	-19.24	17.21	144.55	67.78	66.76	54.12
Net Cash Growth	-	-88.09%	113.25%	1.53%	23.35%	-40.66%
Net Cash Per Share	-1.24	1.11	9.65	5.75	1.67	1.42
Book Value	-21.04	7.99	133.58	43.5	58.06	52.38
Book Value Per Share	-1.36	0.52	8.92	3.69	1.45	1.38
Tangible Book Value	-21.04	7.99	133.58	43.5	58.06	52.38
Tangible Book Value Per Share	-1.36	0.52	8.92	3.69	1.45	1.38

SEC Filings: 10-K · 10-Q